{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:30:46Z","timestamp":1792679446590,"version":"4.5.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["T001018N; G0F8316N"],"award-info":[{"award-number":["T001018N; G0F8316N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Next generation sequencing (NGS) is a powerful technology for diagnosing and managing rifampicin-resistant tuberculosis (RR-TB). To facilitate its integration into routine RR-TB care, a treatment recommendation system was developed to automatically translate whole genome sequencing (WGS) results into treatment recommendations. The effectiveness of WGS-guided treatment recommendations was evaluated in the SMARTT trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a focus group discussion among eleven health care workers (HCWs) involved with managing SMARTT trial participants to explore their experiences and attitudes towards WGS-guided treatment recommendations. Thematic analysis was undertaken with an inductive approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The use of WGS and automated treatment recommendations simplified drug susceptibility testing (DST) and was perceived as beneficial to patients and HCWs. The strategy did not negatively impact HCWs autonomy and competence. Trust and acceptance were compromised by slow turn-around time, guideline deviations, discordance between DST methods, and unfavorable outcomes of some patients. Implementation challenges included drug stock-out, limited internet connection and training requirements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NGS accompanied by automated treatment recommendations holds promise for improving RR-TB care in high-burden settings, benefiting both patients and HCWs. Perspectives of policymakers, laboratory staff and patients should be explored to support the routine implementation of NGS in RR-TB management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0350514","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:23:02Z","timestamp":1782494582000},"page":"e0350514","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potentials and challenges of next generation sequencing-guided individualized treatment for management of rifampicin-resistant tuberculosis \u2013 A qualitative study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-1169","authenticated-orcid":true,"given":"Tu Pham Hien","family":"Trang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4583-5434","authenticated-orcid":true,"given":"Antonio","family":"Barrenechea-Pulache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7272-7757","authenticated-orcid":true,"given":"Katinka","family":"De Wet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boitumelo","family":"Fanampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Van Rie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"pone.0350514.ref001","unstructured":"Global tuberculosis report 2024. Geneva: World Health Organization. 2024."},{"key":"pone.0350514.ref002","unstructured":"WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug resistant tuberculosis treatment - 2022 update. Geneva: World Health Organization. 2022."},{"issue":"3","key":"pone.0350514.ref003","first-page":"684","article-title":"Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline","volume":"72","author":"C Villellas","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"pone.0350514.ref004","unstructured":"Department of Health R. Clinical management of rifampicin-resistant tuberculosis - updated clinical reference guide. 2023."},{"key":"pone.0350514.ref005","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment and care","author":"WHO Global Programme on Tuberculosis and Lung Health","year":"2025"},{"issue":"5","key":"pone.0350514.ref006","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/JCM.02993-14","article-title":"Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases","volume":"53","author":"AA Witney","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"11","key":"pone.0350514.ref007","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/cid\/ciaa526","article-title":"Individualized treatment of multidrug-resistant tuberculosis using whole-genome sequencing and expanded drug-susceptibility testing","volume":"71","author":"N Dookie","year":"2020","journal-title":"Clin Infect Dis"},{"key":"pone.0350514.ref008","doi-asserted-by":"crossref","first-page":"1204064","DOI":"10.3389\/fpubh.2023.1204064","article-title":"Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes","volume":"11","author":"L de Araujo","year":"2023","journal-title":"Front Public Health"},{"key":"pone.0350514.ref009","doi-asserted-by":"crossref","first-page":"775030","DOI":"10.3389\/fmicb.2022.775030","article-title":"Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field","volume":"13","author":"N Dookie","year":"2022","journal-title":"Front Microbiol"},{"issue":"1","key":"pone.0350514.ref010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12911-022-01790-0","article-title":"A treatment recommender clinical decision support system for personalized medicine: method development and proof-of-concept for drug resistant tuberculosis","volume":"22","author":"L Verboven","year":"2022","journal-title":"BMC Med Inform Decis Mak"},{"key":"pone.0350514.ref011","article-title":"A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis","author":"L Verboven","year":"2023","journal-title":"Res Sq"},{"issue":"1","key":"pone.0350514.ref012","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1186\/s13063-022-06793-w","article-title":"Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial","volume":"23","author":"A Van Rie","year":"2022","journal-title":"Trials"},{"issue":"6","key":"pone.0350514.ref013","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S2213-2600(26)00095-0","article-title":"Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial","volume":"14","author":"A Van Rie","year":"2026","journal-title":"Lancet Respir Med"},{"issue":"1","key":"pone.0350514.ref014","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/tmj.2011.0066","article-title":"Using a modified technology acceptance model to evaluate healthcare professionals\u2019 adoption of a new telemonitoring system","volume":"18","author":"MP Gagnon","year":"2012","journal-title":"Telemed J E Health"},{"issue":"12","key":"pone.0350514.ref015","doi-asserted-by":"crossref","DOI":"10.2196\/11072","article-title":"Acceptance and Resistance of New Digital Technologies in Medicine: Qualitative Study","volume":"7","author":"S Safi","year":"2018","journal-title":"JMIR Res Protoc"},{"issue":"3","key":"pone.0350514.ref016","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/10810730.2017.1284286","article-title":"Ready for eHealth? Health Professionals\u2019 Acceptance and Adoption of eHealth Interventions in Inpatient Routine Care","volume":"22","author":"S Hennemann","year":"2017","journal-title":"J Health Commun"},{"issue":"1","key":"pone.0350514.ref017","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1186\/s12913-022-08215-8","article-title":"Challenges to implementing artificial intelligence in healthcare: a qualitative interview study with healthcare leaders in Sweden","volume":"22","author":"L Petersson","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pone.0350514.ref018","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13012-017-0644-2","article-title":"What hinders the uptake of computerized decision support systems in hospitals? A qualitative study and framework for implementation","volume":"12","author":"EG Liberati","year":"2017","journal-title":"Implement Sci"},{"issue":"3","key":"pone.0350514.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hsdr02030","article-title":"The work, workforce, technology and organisational implications of the \u2018111\u2019 single point of access telephone number for urgent (non-emergency) care: a mixed-methods case study","volume":"2","author":"J Turnbull","year":"2014","journal-title":"Health Services and Delivery Research"},{"issue":"9","key":"pone.0350514.ref020","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations","volume":"89","author":"BC O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"issue":"4","key":"pone.0350514.ref021","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066651","article-title":"Complexities and benefits of adopting next-generation sequencing-based tuberculosis diagnostics: a qualitative study among stakeholders in low and high-income countries","volume":"13","author":"S Grandjean Lapierre","year":"2023","journal-title":"BMJ Open"},{"issue":"12","key":"pone.0350514.ref022","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.5588\/ijtld.22.0335","article-title":"A very sneaky bug: perspectives of front-line clinicians on whole-genome sequencing for drug-resistant TB","volume":"26","author":"B Memani","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"pone.0350514.ref023","doi-asserted-by":"crossref","DOI":"10.1136\/medethics-2019-105860","article-title":"Primer on an ethics of AI-based decision support systems in the clinic","volume":"47","author":"M Braun","year":"2020","journal-title":"J Med Ethics"},{"key":"pone.0350514.ref024","doi-asserted-by":"crossref","first-page":"1324963","DOI":"10.3389\/fmed.2024.1324963","article-title":"Physician\u2019s autonomy in the face of AI support: walking the ethical tightrope","volume":"11","author":"F Funer","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"pone.0350514.ref025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12911-023-02162-y","article-title":"The impact of artificial intelligence on the person-centred, doctor-patient relationship: some problems and solutions","volume":"23","author":"A Sauerbrei","year":"2023","journal-title":"BMC Med Inform Decis Mak"},{"issue":"6","key":"pone.0350514.ref026","doi-asserted-by":"crossref","DOI":"10.2196\/15154","article-title":"Artificial Intelligence and Human Trust in Healthcare: Focus on Clinicians","volume":"22","author":"O Asan","year":"2020","journal-title":"J Med Internet Res"},{"issue":"4","key":"pone.0350514.ref027","article-title":"Whole-genome sequencing of Mycobacterium tuberculosis directly from clinical samples for high-resolution genomic epidemiology and drug resistance surveillance: an observational study","volume":"1","author":"GA Goig","year":"2020","journal-title":"Lancet Microbe"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:23:09Z","timestamp":1782494589000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350514"}},"subtitle":[],"editor":[{"given":"Igor","family":"Mokrousov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350514","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}